FDA Approves Alzheimer’s Drug Leqembi
On January 6, 2023, the Food and Drug Administration (FDA) approved a new Alzheimer’s…
NCMS Foundation Webinar: Treating Hepatitis C in Patients with Substance Use Disorders
Register now for the webinar: "Treating Hepatitis C in Patients with Substance Use…